• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Urban Outfitters Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    11/22/23 2:03:09 PM ET
    $ADSK
    $AGIL
    $AGL
    $ANGH
    Computer Software: Prepackaged Software
    Technology
    Professional Services
    Consumer Discretionary
    Get the next $ADSK alert in real time by email

    Shares of Urban Outfitters, Inc. (NASDAQ:URBN) dipped during Wednesday’s session after the company reported third-quarter financial results.

    Urban Outfitters reported quarterly earnings of 88 cents per share, topping the analyst consensus estimate of 82 cents per share. The company reported record quarterly sales of $1.28 billion which exceeded analyst expectations of $1.26 billion, according to data from Benzinga Pro.

    Urban Outfitters shares fell 9.9% to $32.73 on Wednesday.

    Here are some other stocks moving in today's mid-day session.

    Gainers

    • AgileThought, Inc. (NASDAQ:AGIL) shares jumped 206.4% to $0.2514 after gaining 5% on Tuesday.
    • PaxMedica, Inc. (NASDAQ:PXMD) rose 33% to $1.08 as the company announced pricing of $7 million public offering.
    • SciSparc Ltd. (NASDAQ:SPRC) gained 29.5% to $8.25 after the company announced it signed a non-binding letter of intent to merge with a vehicle importer company in Israel.
    • Agape ATP Corporation (NASDAQ:ATPC) climbed 22% to $1.15. Agape ATP announced a $1 million share repurchase plan over the next 6 months.
    • Ryvyl Inc. (NASDAQ:RVYL) rose 21.6% to $3.77. The company recently posted a narrower loss for the third quarter.
    • Heart Test Laboratories, Inc. (NASDAQ:HSCS) shares rose 19.3% to $0.2340. HeartSciences recently announced closing of license agreements with the Icahn School of Medicine at Mount Sinai to develop and commercialize AI cardiovascular algorithms.
    • Safety Shot, Inc. (NASDAQ:SHOT) rose 17.5% to $5.63.
    • Gyre Therapeutics, Inc. (NASDAQ:GYRE) climbed 14.2% to $14.54.
    • Edesa Biotech, Inc. (NASDAQ:EDSA) gained 12.1% to $3.14. HC Wainwright & Co. reiterated Edesa Biotech with a Buy and maintained a $10 price target.
    • agilon health, inc. (NYSE:AGL) climbed 9.3% to $12.02. Deutsche Bank downgraded Agilon Health from Buy to Hold and lowered the price target from $27 to $12.
    • GH Research PLC (NASDAQ:GHRS) gained 8.4% to $6.34.
    • Connect Biopharma Holdings Limited(NASDAQ:CNTB) gained 8% to $1.36 after dipping over 40% on Tuesday. Connect Biopharma Holdings released topline results from Stage 2 (maintenance period) of its China pivotal trial evaluating rademikibart's (formerly known as CBP-201) efficacy and safety in patients with moderate-to-severe atopic dermatitis (AD).
    • VinFast Auto Ltd. (NASDAQ:VFS) gained 7% to $6.41.
    • Safe and Green Development Corporation (NASDAQ:SGD) gained 5% to $3.96. Safe and Green Development shares jumped 33% on Tuesday after the company signed a non-binding Letter of Intent to invest money in Majestic World Holdings in exchange for access to the software platform Xene.
    • HP Inc. (NYSE:HPQ) gained 4.3% to $29.08 following quarterly results.

    Losers

    • Alterity Therapeutics Limited (NASDAQ:ATHE) fell 18.8% to $1.9239.
    • MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) declined 16.6% to $3.2501.
    • Tharimmune, Inc. (NASDAQ:THAR) fell 16.1% to $3.01.
    • Anghami Inc. (NASDAQ:ANGH) fell 14.7% to $2.6505. Anghami shares jumped 97% on Tuesday after the company and OSN+ announced a deal that will combine their businesses.
    • Genenta Science S.p.A. (NASDAQ:GNTA) dipped 14.7% to $4.29.
    • Alpha Technology Group Limited (NASDAQ:ATGL) fell 13.7% to $17.69 on post-IPO volatility.
    • Guess?, Inc. (NYSE:GES) shares fell 11.2% to $21.03 after the company reported worse-than-expected third-quarter financial results and issued fourth-quarter adjusted EPS guidance below estimates.
    • TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) shares fell 11% to $0.1931 after jumping 25% on Tuesday.
    • Emeren Group Ltd (NYSE:SOL) shares fell 8.2% to $2.4050 after posting a loss for the third quarter.
    • Nordstrom, Inc. (NYSE:JWN) fell 6.8% to $13.89 after the company reported third-quarter financial results.
    • Deere & Company (NYSE:DE) fell 6.7% to $356.50 after the company reported fourth-quarter financial results.
    • Autodesk, Inc. (NASDAQ:ADSK) fell 5.8% to $205.07. Autodesk posted upbeat results for the third quarter. The company also said it sees full-year earnings between $7.43 and $7.49 per share and revenue between $5.45 billion and $5.465 billion.
    • Gaotu Techedu Inc. (NYSE:GOTU) fell 5.2% to $2.58 following third-quarter results.

     

    Now Read This: How To Earn $500 A Month From Guess? Stock Following Q3 Earnings Report

    Get the next $ADSK alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADSK
    $AGIL
    $AGL
    $ANGH

    CompanyDatePrice TargetRatingAnalyst
    Autodesk Inc.
    $ADSK
    3/2/2026$343.00 → $279.00Market Perform
    BMO Capital Markets
    Deere & Company
    $DE
    2/23/2026$550.00Hold → Underperform
    Jefferies
    HP Inc.
    $HPQ
    2/3/2026$20.00Neutral → Underperform
    BofA Securities
    Autodesk Inc.
    $ADSK
    2/2/2026$319.00Neutral → Overweight
    Analyst
    HP Inc.
    $HPQ
    1/16/2026$18.00Equal Weight → Underweight
    Barclays
    HP Inc.
    $HPQ
    1/13/2026$21.00Sell
    Goldman
    Autodesk Inc.
    $ADSK
    1/9/2026$375.00Buy
    Rothschild & Co Redburn
    Autodesk Inc.
    $ADSK
    12/17/2025$365.00Buy
    BTIG Research
    More analyst ratings

    $ADSK
    $AGIL
    $AGL
    $ANGH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Nijhawan Pardeep bought $6,599 worth of shares (1,000 units at $6.60), increasing direct ownership by 0.16% to 628,813 units (SEC Form 4)

    4 - Edesa Biotech, Inc. (0001540159) (Issuer)

    3/10/26 5:02:16 PM ET
    $EDSA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Nijhawan Pardeep bought $39,000 worth of shares (10,000 units at $3.90) (SEC Form 4)

    4 - Edesa Biotech, Inc. (0001540159) (Issuer)

    3/6/26 5:01:15 PM ET
    $EDSA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Nijhawan Pardeep bought $42,560 worth of shares (10,000 units at $4.26) (SEC Form 4)

    4 - Edesa Biotech, Inc. (0001540159) (Issuer)

    3/5/26 5:01:11 PM ET
    $EDSA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADSK
    $AGIL
    $AGL
    $ANGH
    SEC Filings

    View All

    HeartSciences Inc. filed SEC Form 8-K: Leadership Update

    8-K - HeartSciences Inc. (0001468492) (Filer)

    4/3/26 5:15:10 PM ET
    $HSCS
    Industrial Specialties
    Health Care

    SEC Form DEFA14A filed by Edesa Biotech Inc.

    DEFA14A - Edesa Biotech, Inc. (0001540159) (Filer)

    4/3/26 4:33:32 PM ET
    $EDSA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEF 14A filed by Edesa Biotech Inc.

    DEF 14A - Edesa Biotech, Inc. (0001540159) (Filer)

    4/3/26 4:31:44 PM ET
    $EDSA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADSK
    $AGIL
    $AGL
    $ANGH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Schwaneke Jeffrey A.

    4 - agilon health, inc. (0001831097) (Issuer)

    4/3/26 7:40:29 PM ET
    $AGL
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 4 filed by Shaker Benjamin

    4 - agilon health, inc. (0001831097) (Issuer)

    4/3/26 7:39:18 PM ET
    $AGL
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 4 filed by Gertsch Timothy

    4 - agilon health, inc. (0001831097) (Issuer)

    4/3/26 7:38:25 PM ET
    $AGL
    Misc Health and Biotechnology Services
    Health Care

    $ADSK
    $AGIL
    $AGL
    $ANGH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Roundtable CEO James Heckman Clarifies Equity Status, Announces One Year Lock

    Ryvyl Adds Veteran former Goldman Sachs Tech Banker Steve Fletcher to Board of Directors In photo: James Heckman, Roundtable Founder and CEO  Seattle, WA, April 02, 2026 (GLOBE NEWSWIRE) -- James Heckman, CEO of AI-driven, Web3 media platform - RTB Digital, Inc. (dba "Roundtable"), following shareholder approval of the company's merger with RYVYL Inc. (NASDAQ:RVYL) outlined the post-merger capitalization table lock-up agreement, and related liquidity considerations; provided additional detail on the recently announced $10 million deposit toward a strategic investment and partnership; and announced a veteran digital media-focused board member. Heckman announced, "about 85% of outstandi

    4/2/26 3:45:00 PM ET
    $RVYL
    Professional Services
    Consumer Discretionary

    Roundtable and RYVYL Announce Shareholders Approve Merger, with 99% of Votes Cast in Favor

    Seattle, WA, April 02, 2026 (GLOBE NEWSWIRE) -- RYVYL Inc. (NASDAQ:RVYL) ("RYVYL" or the "Company"), and RTB Digital Inc.'s (Roundtable) CEO, James Heckman, announced today that the merger was approved at the Company's Special Meeting of Shareholders held on April 1, 2026. The approval removes the final corporate hurdle to complete the merger, and, subject to Nasdaq approval of Roundtable's initial listing application, which has been filed, establishes the foundation to list the combined company on Nasdaq as RTB Digital Inc., expected to be listed under the ticker symbol RTB. The transaction is anticipated to consummate imminently. "We are grateful for the outcome of today's Special Meet

    4/2/26 6:27:00 AM ET
    $RVYL
    Professional Services
    Consumer Discretionary

    New Year, New Savings: VinFast VF 8 Opens the Door Wider With Canada's EV Rebate

    With federal incentives returning, VinFast's VF 8 becomes more attainable than ever, supported by a leading 10-year warranty and integrated charging across North America The Year of the Horse opened at a gallop for VinFast. The company delivered 16,172 electric vehicles in Vietnam in January alone, a 55% jump over the same month last year1. It was the 16th straight month that VinFast held the top spot in its home market, the "sweet fruit" of eight years spent playing the long game and building a comprehensive EV ecosystem in Vietnam, spanning products, charging infrastructure and aftersales support. In the latest delivery figures, two new models in the VinFast lineup, the compact Minio

    4/2/26 6:00:00 AM ET
    $VFS
    Auto Manufacturing
    Industrials

    $ADSK
    $AGIL
    $AGL
    $ANGH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BMO Capital Markets reiterated coverage on Autodesk with a new price target

    BMO Capital Markets reiterated coverage of Autodesk with a rating of Market Perform and set a new price target of $279.00 from $343.00 previously

    3/2/26 8:16:50 AM ET
    $ADSK
    Computer Software: Prepackaged Software
    Technology

    Deere downgraded by Jefferies with a new price target

    Jefferies downgraded Deere from Hold to Underperform and set a new price target of $550.00

    2/23/26 8:30:50 AM ET
    $DE
    Industrial Machinery/Components
    Industrials

    HP Inc. downgraded by BofA Securities with a new price target

    BofA Securities downgraded HP Inc. from Neutral to Underperform and set a new price target of $20.00

    2/3/26 10:06:05 AM ET
    $HPQ
    Computer Manufacturing
    Technology

    $ADSK
    $AGIL
    $AGL
    $ANGH
    Leadership Updates

    Live Leadership Updates

    View All

    Roundtable CEO James Heckman Clarifies Equity Status, Announces One Year Lock

    Ryvyl Adds Veteran former Goldman Sachs Tech Banker Steve Fletcher to Board of Directors In photo: James Heckman, Roundtable Founder and CEO  Seattle, WA, April 02, 2026 (GLOBE NEWSWIRE) -- James Heckman, CEO of AI-driven, Web3 media platform - RTB Digital, Inc. (dba "Roundtable"), following shareholder approval of the company's merger with RYVYL Inc. (NASDAQ:RVYL) outlined the post-merger capitalization table lock-up agreement, and related liquidity considerations; provided additional detail on the recently announced $10 million deposit toward a strategic investment and partnership; and announced a veteran digital media-focused board member. Heckman announced, "about 85% of outstandi

    4/2/26 3:45:00 PM ET
    $RVYL
    Professional Services
    Consumer Discretionary

    Alterity Therapeutics Appoints Daniel O. Claassen, M.D., M.S., as Chief Medical Advisor

    MELBOURNE, Australia and SAN FRANCISCO, March 04, 2026 (GLOBE NEWSWIRE) -- Alterity Therapeutics ((ASX: ATH, NASDAQ:ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that Daniel O. Claassen, M.D., M.S., was appointed Chief Medical Advisor and will begin his role in March 2026. As a tenured professor, Dr. Claassen will also retain his academic appointment at Vanderbilt University Medical Center. Dr. Claassen is a board-certified neurologist and internationally recognized expert in neurodegenerative diseases, with more than two decades of clinical and translational research in mov

    3/4/26 7:25:00 AM ET
    $ATHE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Genenta Advances Transformation into Saentra Forge, Strengthens ATC Governance and Expands Strategic Industrial Consolidation Platform

    MILAN, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Genenta Science S.p.A. (NASDAQ:GNTA) in transformation to Saentra Forge (NASDAQ:SAEN), a strategic industrial consolidator focused on biotech, defense, aerospace, and national-security-related technologies, today announced the appointment of Paolo Salvato to the Board of Directors of ATC, a manufacturer of tactical defense systems representing the Company's initial entry into defense technology manufacturing. The Company also provided an update on its ongoing evaluation of majority-control acquisition opportunities in regulated national-security sectors. Mr. Salvato previously served as Chief Executive Officer of Fiocchi Munizioni S.p.A. (CSG Group

    2/27/26 4:00:00 AM ET
    $GNTA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADSK
    $AGIL
    $AGL
    $ANGH
    Financials

    Live finance-specific insights

    View All

    Rademikibart Demonstrates Best-in-Class Potential in Phase 3 Atopic Dermatitis Study

    – Rademikibart achieved rapid, durable efficacy results across all key endpoints through 52 weeks, with near‑maximal responses achieved in ~90% of patients – – Rademikibart was well tolerated with safety comparable to placebo – – Data presented during late-breaking oral presentation at 2026 American Academy of Dermatology Annual Meeting –  – Company to host conference call and webcast today, March 30, 2026 at 8:00 a.m. ET – SAN DIEGO, March 30, 2026 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (NASDAQ:CNTB) (Connect Biopharma, Connect or the Company), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory diseases, today anno

    3/30/26 7:01:00 AM ET
    $CNTB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Connect Biopharma Announces Positive Topline Data from its Phase 1 Study of Intravenous (IV) Rademikibart in Patients with Asthma or COPD

    – Rademikibart administered as a single 300 mg 2-minute IV push to asthma and chronic obstructive pulmonary disease (COPD) patients produced rapid improvement in FEV1 with many patients experiencing improvements in airway function of ≥200 mL as early as 15 minutes post-dosing – – The rapid improvement in FEV1 demonstrated with IV rademikibart in this study provides clinical confirmation of preclinical observations that rademikibart has a unique beneficial effect on bronchodilation – – Mean FEV1 improvements of ~200 - 400 mL were maintained through Day 29 in asthma and COPD patients – – Recruitment ongoing for Phase 2 Seabreeze STAT studies for acute exacerbations in asthma and COPD;

    3/30/26 7:00:00 AM ET
    $CNTB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    VinFast Reports Preliminary and Unaudited Fourth Quarter and Full Year 2025 Financial Results

    SINGAPORE, March 16, 2026 /PRNewswire/ -- VinFast Auto Ltd. ("VinFast" or the "Company") (NASDAQ:VFS), a pure-play electric vehicle ("EV") manufacturer with the mission of making EVs accessible to everyone, today announced its preliminary and unaudited financial results for the fourth quarter and full year ended December 31, 2025.  EV deliveries were 86,557 in the fourth quarter of 2025, representing a 127% increase quarter-over-quarter and a 63% increase year-over-year. Among those, the commercial models under the Green brand and the EC Van model accounted for approximately 49%

    3/16/26 10:43:00 AM ET
    $VFS
    Auto Manufacturing
    Industrials

    $ADSK
    $AGIL
    $AGL
    $ANGH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Gaotu Techedu Inc.

    SC 13G/A - Gaotu Techedu Inc. (0001768259) (Subject)

    11/27/24 6:02:40 AM ET
    $GOTU
    Other Consumer Services
    Real Estate

    Amendment: SEC Form SC 13D/A filed by Anghami Inc.

    SC 13D/A - Anghami Inc (0001871983) (Subject)

    11/19/24 4:15:31 PM ET
    $ANGH
    Telecommunications Equipment
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by TRACON Pharmaceuticals Inc.

    SC 13G/A - Tracon Pharmaceuticals, Inc. (0001394319) (Subject)

    11/14/24 8:51:58 PM ET
    $TCON
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care